Identification of a Subtype of Hepatocellular Carcinoma with Poor Prognosis Based on Expression of Genes Within the Glucose Metabolic Pathway

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2019 Dec 19

PMID 31847435

Citations 12

Authors

Xiaoli Zhang

Jin Li

Kalpana Ghoshal

Soledad Fernandez

Lang Li

Affiliations

Soon will be listed here.

Abstract

Hepatocellular carcinoma (HCC) is the most prevalent primary cancer and a highly aggressive liver malignancy. Liver cancer cells reprogram their metabolism to meet their needs for rapid proliferation and tumor growth. In the present study, we investigated the alterations in the expression of the genes involved in glucose metabolic pathways as well as their association with the clinical stage and survival of HCC patients. We found that the expressions of around 30% of genes involved in the glucose metabolic pathway are consistently dysregulated with a predominant down-regulation in HCC tumors. Moreover, the differentially expressed genes are associated with an advanced clinical stage and a poor prognosis. More importantly, unsupervised clustering analysis with the differentially expressed genes that were also associated with overall survival (OS) revealed a subgroup of patients with a worse prognosis including reduced OS, disease specific survival, and recurrence-free survival. This aggressive subtype had significantly increased expression of stemness-related genes and down-regulated metabolic genes, as well as increased immune infiltrates that contribute to a poor prognosis. Collectively, this integrative study indicates that expressions of the glucose metabolic genes could be used as potential prognostic markers and/or therapeutic targets, which might be helpful in developing precise treatment for patients with HCC.

Citing Articles

CCPA: cloud-based, self-learning modules for consensus pathway analysis using GO, KEGG and Reactome.

Nguyen H, Pham V, Nguyen H, Tran B, Petereit J, Nguyen T Brief Bioinform. 2024; 25(Supplement_1).

PMID: 39041916 PMC: 11264295. DOI: 10.1093/bib/bbae222.

Fasting in combination with the cocktail Sorafenib:Metformin blunts cellular plasticity and promotes liver cancer cell death via poly-metabolic exhaustion.

Lopez-Canovas J, Naranjo-Martinez B, Diaz-Ruiz A Cell Oncol (Dordr). 2024; 48(1):161-182.

PMID: 38990489 PMC: 11850423. DOI: 10.1007/s13402-024-00966-2.

Association of mitochondrial phosphoenolpyruvate carboxykinase with prognosis and immune regulation in hepatocellular carcinoma.

Li C, Zhang E, Ye Y, Xiao Z, Huang H, Zeng Z Sci Rep. 2024; 14(1):14051.

PMID: 38890507 PMC: 11189538. DOI: 10.1038/s41598-024-64907-7.

Cancer Stem Cells from Definition to Detection and Targeted Drugs.

Ruszkowska-Ciastek B, Kwiatkowska K, Marques-da-Silva D, Lagoa R Int J Mol Sci. 2024; 25(7).

PMID: 38612718 PMC: 11011379. DOI: 10.3390/ijms25073903.

Integration with Transcriptomic and Metabolomic Analyses Reveals the Cytotoxic Mechanisms of Chinese Poplar Propolis by Triggering the Glucose Metabolism in Human Hepatocellular Carcinoma Cells.

Guo Y, Liu Z, Wu Q, Li Z, Yang J, Xuan H Nutrients. 2023; 15(20).

PMID: 37892405 PMC: 10610315. DOI: 10.3390/nu15204329.

References

Khan M, Priyadarshini M, Cordoba-Chacon J, Becker T, Layden B . Hepatic hexokinase domain containing 1 (HKDC1) improves whole body glucose tolerance and insulin sensitivity in pregnant mice. Biochim Biophys Acta Mol Basis Dis. 2018; 1865(3):678-687. PMC: 6387585. DOI: 10.1016/j.bbadis.2018.11.022. View

Wakizaka K, Yokoo H, Kamiyama T, Kakisaka T, Ohira M, Tani M . CD133 and epithelial cell adhesion molecule expressions in the cholangiocarcinoma component are prognostic factors for combined hepatocellular cholangiocarcinoma. Hepatol Res. 2019; 50(2):258-267. DOI: 10.1111/hepr.13443. View

Lunt S, Vander Heiden M . Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol. 2011; 27:441-64. DOI: 10.1146/annurev-cellbio-092910-154237. View

Chang Y, Chiou J, Yang Y, Su C, Lin Y, Yang C . Therapeutic Targeting of Aldolase A Interactions Inhibits Lung Cancer Metastasis and Prolongs Survival. Cancer Res. 2019; 79(18):4754-4766. DOI: 10.1158/0008-5472.CAN-18-4080. View

Vander Heiden M, Cantley L, Thompson C . Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009; 324(5930):1029-33. PMC: 2849637. DOI: 10.1126/science.1160809. View

Tseng C, Kuo W, Chan S, Chan H, Chang K, Wang L . Transketolase Regulates the Metabolic Switch to Control Breast Cancer Cell Metastasis via the α-Ketoglutarate Signaling Pathway. Cancer Res. 2018; 78(11):2799-2812. DOI: 10.1158/0008-5472.CAN-17-2906. View

Wang R, Li Y, Tsung A, Huang H, Du Q, Yang M . iNOS promotes CD24CD133 liver cancer stem cell phenotype through a TACE/ADAM17-dependent Notch signaling pathway. Proc Natl Acad Sci U S A. 2018; 115(43):E10127-E10136. PMC: 6205478. DOI: 10.1073/pnas.1722100115. View

Kim Y, Jeong D, Pak K, Han M, Kim J, Liangwen L . SLC2A2 (GLUT2) as a novel prognostic factor for hepatocellular carcinoma. Oncotarget. 2017; 8(40):68381-68392. PMC: 5620264. DOI: 10.18632/oncotarget.20266. View

Pavlova N, Thompson C . The Emerging Hallmarks of Cancer Metabolism. Cell Metab. 2016; 23(1):27-47. PMC: 4715268. DOI: 10.1016/j.cmet.2015.12.006. View

10.

Principe M, Borgoni S, Cascione M, Chattaragada M, Ferri-Borgogno S, Capello M . Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis. J Hematol Oncol. 2017; 10(1):16. PMC: 5237223. DOI: 10.1186/s13045-016-0385-8. View

11.

Wang J, Zhang P, Zhong J, Tan M, Ge J, Tao L . The platelet isoform of phosphofructokinase contributes to metabolic reprogramming and maintains cell proliferation in clear cell renal cell carcinoma. Oncotarget. 2016; 7(19):27142-57. PMC: 5053638. DOI: 10.18632/oncotarget.8382. View

12.

Grasmann G, Smolle E, Olschewski H, Leithner K . Gluconeogenesis in cancer cells - Repurposing of a starvation-induced metabolic pathway?. Biochim Biophys Acta Rev Cancer. 2019; 1872(1):24-36. PMC: 6894939. DOI: 10.1016/j.bbcan.2019.05.006. View

13.

Gatenby R, Gillies R . Why do cancers have high aerobic glycolysis?. Nat Rev Cancer. 2004; 4(11):891-9. DOI: 10.1038/nrc1478. View

14.

Nishida N, Kudo M . Immunological Microenvironment of Hepatocellular Carcinoma and Its Clinical Implication. Oncology. 2016; 92 Suppl 1:40-49. DOI: 10.1159/000451015. View

15.

Hyuga S, Wada H, Eguchi H, Otsuru T, Iwgami Y, Yamada D . Expression of carbonic anhydrase IX is associated with poor prognosis through regulation of the epithelial‑mesenchymal transition in hepatocellular carcinoma. Int J Oncol. 2017; 51(4):1179-1190. DOI: 10.3892/ijo.2017.4098. View

16.

Rousset M, Paris H, Chevalier G, Terrain B, Murat J, ZWEIBAUM A . Growth-related enzymatic control of glycogen metabolism in cultured human tumor cells. Cancer Res. 1984; 44(1):154-60. View

17.

. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017; 169(7):1327-1341.e23. PMC: 5680778. DOI: 10.1016/j.cell.2017.05.046. View

18.

Lee J, Liu R, Li J, Zhang C, Wang Y, Cai Q . Stabilization of phosphofructokinase 1 platelet isoform by AKT promotes tumorigenesis. Nat Commun. 2017; 8(1):949. PMC: 5643558. DOI: 10.1038/s41467-017-00906-9. View

19.

Yin H, Wang L, Liu H . ENO1 Overexpression in Pancreatic Cancer Patients and Its Clinical and Diagnostic Significance. Gastroenterol Res Pract. 2018; 2018:3842198. PMC: 5816842. DOI: 10.1155/2018/3842198. View

20.

Calvisi D, Ladu S, Gorden A, Farina M, Lee J, Conner E . Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma. J Clin Invest. 2007; 117(9):2713-22. PMC: 1950459. DOI: 10.1172/JCI31457. View